Record 71–30–F
Classification: Level 0 – Restricted Access
(Requires dual-seal approval from both the Atlas Foundation Director and the VIC Director)
Source: [REDACTED]
Codename: HOPE
----------------------------------------------------------------------------------------------
Day 1 – Initial Injection
Subjects injected with [REDACTED] demonstrate significant improvements in both cognitive processing and reaction speed. Recorded average response time: 150 milliseconds. Best recorded case: 50 milliseconds. Several subjects displayed early subconscious control, including instances of parallel thought. No immediate signs of rejection were observed, marking substantial progress compared to previous trials. Extended observation period scheduled prior to Phase II initiation.
Day 13 – Attrition Report
Of 50 original subjects, 20 remain. Primary causes of mortality: catastrophic neural burnout, uncontrolled cardiac failure, and blood pressure collapse. Example case: one subject suffered fatal cardiac rupture at the 30 km mark of a 50 km endurance trial. Autopsy revealed severe [REDACTED] malfunction, resulting in damage to the spinal column and medulla part of the brain. The remaining 20 subjects continue to exhibit exceptional control of [REDACTED] and have been cleared for Phase II.
Day 15 – Augmentation Phase
Exoskeletal integration and nanobot factory implantation completed. Results:
15 subjects assimilated without complication.
2 subjects showed minor rejection, stabilized through nanobot regulation.
2 subjects entered irreversible comatose states; prognosis: cortical overload, permanent vegetative condition.
1 subject deceased during the procedure.
Surviving 15 subjects granted 72 hours of recovery before progression to Phases III and IV.
Day 35 – Field Viability
All subjects exhibit exceptional combat potential. Testing confirmed resilience against two direct impacts from .50 BMG rounds before critical skeletal or dermal failure. Koronium outer-layer formation, facilitated by nanobot activity, provides significant ballistic resistance. Recovery protocols are extraordinary:
Total brain destruction recoverable within ~6 days, provided [REDACTED] and nanobot factory remain functional.
Other severe injuries are recoverable within 1–2 hours, barring total amputation or vaporization.
All subjects display advanced endocrine regulation, including complete suppression of pain receptors at will.
Conclusion:
Project [REDACTED] deemed operationally viable.
Subjects approved for frontline deployment.
And [REDACTED] are ready for mass production.
Signature:
J. Red
Director, Atlas Foundation
---------------------------------------------------------------------------------------------
Archivist's Note
This report is believed to document the precursor to Project [REDACTED], the eventual civilian-adaptable variant. While the losses recorded here were severe, subsequent accounts suggest the program's deployment marked a turning point in the war. The sacrifices made were later justified under the maxim: "the result justifies the cost."